Biogen | BIIB - Trade Creditors


Biogen reported $432M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
ALKERMES USD 107.95M 39.95M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Bayer EUR 7.08B 700M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Gilead Sciences USD 715M 93M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Merck USD 4.15B 102M Sep/2025
Moderna USD 317M 50M Dec/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 22.71B 219M Mar/2026
Sanofi EUR 22.93B 2.89B Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025